People · Operator
Named in public records as an officer, director or promoter · active 2017–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oyster Point Pharma, Inc. | — | Pharmaceuticals | Series C | $113.6M | $3.0B | 2017 |
Ali J Behbahani at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ali J Behbahani on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William J. Link | 1 | 10 |
| Mark A. Murray | 1 | 2 |
| D. Michael Ackermann | 1 | 1 |
| Clare A. Ozawa | 1 | 1 |
| Benjamin A. Tsai | 1 | 1 |
| Jeffrey A. Nau | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.